TABLE 2.
Effects of amino acid substitutions in hu-CCR5 and rh-CCR5 on HIV-1 Env pseudotype infectivity in a single-round assay
CCR5 construct | Result for the following Env-pseudotyped virus:
|
|||||
---|---|---|---|---|---|---|
HIVJR-FLa
|
HIVADAb
|
HIVYU2c
|
||||
Relative IC50d | % Inhibitione | Relative IC50 | % Inhibition | Relative IC50 | % Inhibition | |
hu-CCR5 | 1 | 95.3 ± 0.6 | 1 | 97.9 ± 0.7 | 1 | 98.7 ± 0.6 |
rh-CCR5f | 240 ± 15 | 57.3 ± 2.1 | >490 | 51.5 ± 7.4 | >390 | 61.8 ± 8.2 |
hu-CCR5(I9T) | 0.6 ± 0.1 | 97.4 ± 1.4 | 0.2 | 99 | 2.3 | 98 |
hu-CCR5(N13D) | 2.1 ± 0.1 | 95.9 ± 1.2 | 2.0 | 98 | 0.7 | 99 |
hu-CCR5(M49I) | 1.0 ± 0.6 | 95.2 ± 0.3 | 0.9 | 99 | 1.5 ± 1.0 | 99.1 ± 0.7 |
hu-CCR5(I52V) | 0.3 ± 0.1 | 97.1 ± 1.9 | ND | ND | 1.5 | 100 |
hu-CCR5(F78L) | 0.6 ± 0.1 | 97.5 ± 1.2 | 0.1 | 100 | 0.6 ± 0.3 | 100 |
hu-CCR5(V130I) | 3.7 ± 3.5 | 96.0 ± 2.5 | 0.5 | 98 | 1.8 | 97 |
hu-CCR5(K171R) | 0.6 ± 0.4 | 96.4 ± 2.0 | 1.8 | 98 | 0.2 | 98 |
hu-CCR5(I198M) | >250 | 21.0 ± 16.6 | >3,700 | 49 | 450 | 54 |
rh-CCR5(M198I) | 0.8 ± 0.2 | 95.3 ± 3.1 | ND | ND | 2.1 | 93 |
n = 5 for hu-CCR5; n = 4 for rh-CCR5(M198I); n = 3 for rh-CCR5 and hu-CCR5(I198M); n = 2 for hu-CCR5(I9T), hu-CCR5(N13D), hu-CCR5(M49I), hu-CCR5(I52V), hu-CCR5(F78L), hu-CCR5(V130I), and hu-CCR5(K171R). Values are means ± standard errors of the means where n is >2 and means ± ranges where n is 2.
n = 5 for hu-CCR5 and n = 4 for rh-CCR5; values are means ± standard errors of the means. n = 1 for all other CCR5 constructs. ND, not done.
n = 5 for hu-CCR5 and n = 4 for rh-CCR5; values are means ± standard errors of the means. n = 2 for hu-CCR5(M49I) and hu-CCR5(F78L); values are means ± ranges. n = 1 for all other CCR5 constructs.
IC50 were obtained from individual data sets fit to a sigmoidal dose-response curve by nonlinear regression using the Prism program (GraphPad Software) and were normalized to the IC50 for hu-CCR5 in the same experiment.
Percent inhibition is the average percent reduction in luciferase activity at 1 μM SCH-C.
Boldfaced values indicate those CCR5 constructs for which inhibition by SCH-C was significantly reduced relative to that for hu-CCR5.